In addition to contributing an extensive portfolio of NHLBI-funded medical research projects from which to select projects for development, each partner institution has strong, but different translational research resources to access. Notable examples include all six partnering institutions participating in the NIH sponsored Clinical and Translational Science Awards (CTSA) program, the National Center for Regenerative Medicine at Case Western Reserve University, the state-of-the-art drug discovery centers at the University of Cincinnati and The Ohio State University, and the recently formed Ohio statewide Clinical Trials Collaborative.
A unique strength of the Center is that strong inter-institutional collaborative relationships in innovation have long been established across the group through the CTSA programs, the Global Cardiovascular Innovation Center (GCIC) program, and the I-Corps@Ohio program.
At each of the partner institutions appointed site directors provide a primary point of contact and liaison function in these areas:
- To broadly communicate and promote program activities within the institution.
- To help to identify and recommend investigators and potential projects for funding.
- To help to identify and recommend investigators for education and skills development offerings.
- To facilitate access to and/or manage sources for project matching funds.
- To help to navigate subgrant processes with local institution grant administration.
In addition, members of the partner institution technology transfer/commercialization offices play very important roles in the identification and qualification of projects for potential funding as well as promotion of those technologies for partnering and licensing opportunities.
End of main page content.